Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-266436

Director acquired 1,429 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Saad Mark E · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-08 Exercise or conversion : show line 1 in the form +1,429 11,431 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-08 Exercise or conversion : show line 2 in the form Restricted Stock Units −1,429 0 D
Loading xslF345X06/ownership.xml…